Eyal Lifschitz is the Co-Founder and Managing General Partner of Peregrine Ventures. See sector focus and contact routes.
Eyal Lifschitz is the Co-Founder and Managing General Partner of Peregrine Ventures, a global life science venture capital fund based in Or Yehuda, Israel. Prior to founding the firm, he was an entrepreneur since the 1990s who co-founded and led business development for medical technology companies including PharmaSys, ECR, Visioncare Ophthalmic Technologies, and BioControl Ltd. His investment thesis targets early-stage high-tech companies, with a strong emphasis on Life Sciences, Digital Health, and Information Technology, primarily in Israel. Peregrine Ventures focuses on seed and pre-seed investments in medical devices, biotech, and digital health sectors. Notable portfolio companies where Lifschitz serves on the board include Valtech Cardio Ltd, NLT SPINE Ltd, CardioGard Ltd, and Restore Medical, where he is Chairman. He also previously served as a Director of Given Imaging (NASDAQ: GIVN) from 2003 to 2007. Lifschitz distinguishes his point of view by advising founders to validate market demand early, engage key opinion leaders and clinicians, and build a valid reimbursement strategy before scaling.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Or Yehuda when building a target list.
Investors like Eyal Lifschitz · Full investor directory · Investor access · Company funding database